Mannheim, Germany

Bransilav Babic

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Diabetes Care, Inc.. Active years: 2016.


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bransilav Babic: Innovator in Diagnostic Storage Solutions

Introduction

Bransilav Babic is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of diagnostic storage solutions, particularly through his innovative patent that addresses the challenges associated with hydrophobizing agents.

Latest Patents

Bransilav Babic holds a patent titled "Protection from hydrophobizing agents." This invention focuses on storage containers designed for diagnostic elements that have a hydrophilic or hydrophilically coated surface. The patent also encompasses analytical measuring devices that utilize these specialized storage containers. Additionally, it highlights the use of an absorption material for selectively absorbing hydrophobic, volatile substances within such containers.

Career Highlights

Throughout his career, Bransilav Babic has worked with prominent companies in the healthcare sector. Notably, he has been associated with Roche Diabetes Care, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative solutions for diagnostic applications.

Collaborations

Bransilav has collaborated with various professionals in his field, including his coworker Wilhelm Leichner. Their joint efforts have further advanced the development of effective diagnostic storage solutions.

Conclusion

Bransilav Babic's contributions to the field of diagnostic storage solutions through his patent and career experiences highlight his role as an innovator. His work continues to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…